Kelley Kendle serves as the CEO and Chair of ClariMed, Inc. since August 2022 and holds an Operating Partner position at NaviMed Capital from July 2021. In addition, Kelley is a Board Member at Canopy Life Sciences and JPA Health. Kelley has been with KHK Advisory as a Principal Advisor focusing on portfolio, acquisition, and growth since May 2019. Previously, Kelley had a longstanding career at Certara from June 2002 to May 2019, where roles included Chief Solutions Officer, CEO, and President of the Global Division Head Regulatory Strategy, Science and Services. Educational qualifications include a BS in Finance and Operations Management, with minors in Economics and International Business from the Alfred Lerner College of Business & Economics at the University of Delaware.
Sign up to view 0 direct reports
Get started